All In Biotech

Drug Trial Radar · NCT07308769

Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

Last checked: Nov 20, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 146 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

146

Planned (sponsor's estimate)

Start

Dec 11, 2025

Primary completion

Oct 2026

Study completion Oct 2026

Sponsor

Lead sponsor
Pharmanutra S.p.a.Industry
Sponsor type
Industry
First posted
Dec 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to compare two oral iron treatments, Sucrosomial® Iron and Ferric Maltol, in women with mild to moderate iron deficiency anemia. Many patients experience gastrointestinal side effects or poor tolerability with traditional iron supplements, which may limit adherence. Participants will be randomly assigned to receive either Sucrosomial® Iron or Ferric Maltol for 12 weeks. The primary objective is to determine whether Sucrosomial® Iron is as effective as Ferric Maltol in normalizing hemoglobin levels.

Conditions

  • Anemia
  • Iron Deficiency Anemia (IDA)

Interventions

  • Sucrosomial® Iron (Sideral® Forte)Dietary supplement

    Sucrosomial® Iron (Sideral® Forte), 30 mg elemental iron per capsule

  • Ferric Maltol (Feraccru®)Drug

    Ferric Maltol (Feraccru®), 30 mg elemental iron per capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hemoglobin normalization at week 12Time frame: Week 12 (End of Treatment)

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital Quironsalud Barcelona

    Barcelona, Spain · Recruiting

  • Hospital Universitari Dexeus Grupo Quironsalud

    Barcelona, Spain · Recruiting

  • Hospital Universitari Sagrat Cor

    Barcelona, Spain · Recruiting

  • Hospital Quironsalud Malaga

    Málaga, Spain · Recruiting

  • Hospital Quironsalud Malága

    Málaga, Spain · Recruiting

  • Hospital Universitari General De Catalunya

    Sant Cugat del Vallès, Spain · Recruiting

  • Hospital Quironsalud Zaragoza

    Zaragoza, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.